Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01504880 · ClinicalTrials.gov registry record

Atrioventricular Valve Regurgitation Vena Contracta; Echo Versus MRI

A clinical trial of Mitral Valve Regurgitation and Tricuspid Valve Regurgitation, Non-rheumatic, sponsored by Medical College of Wisconsin.

Completed
Registry status
3
Enrollment target
1
Study location

NCT01504880 is a study of Mitral Valve Regurgitation and Tricuspid Valve Regurgitation, Non-rheumatic that has completed, run by Medical College of Wisconsin. The registered enrollment target is 3 participants, below the 814-participant average among 11 other Mitral Valve Regurgitation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01504880, a study of Mitral Valve Regurgitation and Tricuspid Valve Regurgitation, Non-rheumatic, has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
3 participants
Enrollment target
1
Study location

Study Summary

The purpose of this pilot study is to evaluate mitral (left atrioventricular valve) and tricuspid (right atrioventricular valve (AVV)) regurgitation using cardiac magnetic resonance imaging (CMR) as the non-invasive "gold standard" compared to transthoracic echocardiography (TTE) to evaluate measurements of the width of the regurgitation jet (vena contracta (VC)) to demonstrate the utility of the VC as a means to objectively evaluate atrioventricular valve regurgitation. In addition, feasibility and other quantitative and qualitative measures of regurgitation will be compared between CMR and TTE. * Hypothesis 1: The ability to objectively evaluate atrioventricular valve regurgitation and VC width with TTE and CMR has a high feasibility rate with acceptable intra and inter-observer variability by two independent readers. * Hypothesis 2: There will be positive correlation between the TTE measurement of the VC width and quantitative assessment of atrioventricular valve regurgitation by TTE and CMR. * Hypothesis 3: There will be a positive correlation between the quantitative measurements of atrioventricular valve regurgitation by phase contrast velocity encoded CMR with quantitative values as measured by TTE. * Hypothesis 4: There will be a positive correlation between qualitative assessment of atrioventricular valve regurgitation by CMR compared to TTE.

Conditions Studied

Mitral Valve Regurgitation Tricuspid Valve Regurgitation, Non-rheumatic

Study Locations (1)

Wisconsin

  • Children's Hospital of Wisconsin - Milwaukee

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2010-06
Est. Completion 2019-12-19

Sponsor

Medical College of Wisconsin

447 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01504880

The ClinicalTrials.gov registry entry for NCT01504880 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 814-participant average among 11 other Mitral Valve Regurgitation trials with a reported enrollment target (100% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mitral Valve Regurgitation appearing as the primary indexed condition, and to 0 interventions.

NCT01504880 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT01504880 about?

NCT01504880 is a clinical study titled "Atrioventricular Valve Regurgitation Vena Contracta; Echo Versus MRI". The purpose of this pilot study is to evaluate mitral (left atrioventricular valve) and tricuspid (right atrioventricular valve (AVV)) regurgitation using cardiac magnetic resonance imaging (CMR) as the non-invasive "gold standard" compared to transthoracic echocardiography (TTE) to evaluate measure...

What is the current status of trial NCT01504880?

This trial is currently completed. The enrollment target is 3 participants. The study started on 2010-06. Estimated completion is 2019-12-19.

What conditions does trial NCT01504880 study?

This clinical trial studies the following conditions: Mitral Valve Regurgitation, Tricuspid Valve Regurgitation, Non-rheumatic.

Who is sponsoring clinical trial NCT01504880?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01504880 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mitral Valve Regurgitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mitral Valve Regurgitation

All registered trials for this condition

Tricuspid Valve Regurgitation, Non-rheumatic

All registered trials for this condition

Wisconsin

All trials with a study site in Wisconsin

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.